Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.24.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GK.2.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.1.5.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HE.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JM.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
KK.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FY.1.4.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JN.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JG.3.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.27.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.1.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GK.1.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GK.8.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GK.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XENUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XCVNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
BA.2.31.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.50NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.78NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.43NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HR.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HK.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HS.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HH.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HU.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
BA.5.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BQ.1.1.27NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BF.7.22NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GP.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.3.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBVNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.277NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.294NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.81NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HV.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.2.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
KK.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.3.17NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FG.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GN.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FY.1.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
B.1.413NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FY.5.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JD.1.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.268NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.409NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FG.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used